Este contenido solo está disponible en inglés.
As per Reuter's report, India's second-largest drugmaker by sales, Dr Reddy's Laboratories Ltd, will buy some established brands of Belgian drugmaker UCB SA in South Asia for 8 billion rupees ($128.38 million). Dr. Reddy's is a premier Indian pharmaceutical company having office in Venezuela. It has a business of about $140 million in Venezuelan market.